Sign Up | Log In | What is SocialPicks?

Encysive Pharmaceuticals Inc (ENCY) Trade Now » Rate ENCY - Discuss ENCY - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate ENCY:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

ENCY Analysis & Videos »

... View All >

ENCY: Bull or Bear?

ENCY - Might bounce back. ENCY

N/A

ENCY dropped hugely due to a failed FDA Approval news. I think it dropped more than 45% in a day. My rationale for picking this stock is that the sell off is an overreaction by the public. The company still has some good products in hand and might succeed in the long run. However, I am planning on a short-term trade. 2 to 3 weeks. It should come back up to 2.50 from the current level of 2.18. Let us wait and see....

Continue reading »

By stockchathub.com (+0.00% risk: aggressive) 06/20/07

Comment

... View All >

People Bullish on ENCY

Manuel C

Analyst

47%

over 2 years ago

Failureisthat

Analyst

N/A

over 2 years ago

stockchathub.com

Analyst

N/A

over 2 years ago

Chrisd312

Sr. Analyst

17%

over 2 years ago

faineant

Analyst

23%

over 2 years ago

People Bearish on ENCY

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	378
2	Gerald Greene	18.14	+70.10%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.30%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
FRE	Freddie Mac
INTC	Intel Corp
DELL	Dell Inc
GM	General Motors Corp
F	Ford Motor Company
BIDU	Baiducom Inc ADS

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla

... more »

StreetInsider.com on ENCY

Form 4 ENCYSIVE PHARMACEUTICALS For: Jun 10 Filed by: THOMSON JAMES A

Form 4 ENCYSIVE PHARMACEUTICALS For: Jun 10 Filed by: DIXON RICHARD A F

Form 4 ENCYSIVE PHARMACEUTICALS For: Jun 10 Filed by: CRUIKSHANK ROBERT J

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.

Following Today's Kosan (KOSN) Buyout, Investors Look for Next Biotech Deal

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Encysive Pharmaceuticals Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.